Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. DPOH name: PANETTA, VINCENT
Share this search Create an alert

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (2)
Results: 1-2 | Export
  1. The Hospital for Sick Children (SickKids)
    Type: In-house Organization
    Occurred: 2017-11-24
    Posted: 2017-12-15
    Designated public office holders:
    • Christopher Antonio, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Chad Sheehy, Manager, Clinical Trial and Biological Product Compliance, Regulatory Operations and Regions Branch | Health Canada (HC)
    • Emily Griffiths, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Vincent Panetta, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Carole Legare, Director, Office of Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, DGO, Health Products and Food Branch | Health Canada (HC)
    • Daniel Keene, A/Chief, Clinical Trials Division & Head Drug Safety Unit, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  2. Alliance of Safe Biologic Medicines
    Type: Consultant
    Lobbyist: Giancarlo Drennan, Maple Leaf Strategies
    Occurred: 2017-10-04
    Posted: 2017-10-18
    Designated public office holders:
    • Georgette Roy, Director, Office of Regulatory Affairs | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Office of Regulatory Affairs | Health Canada (HC)
    • Vincent Panetta, Regulatory Affairs Supervisor, Office of Regulatory Affairs | Health Canada (HC)
    • Anthony Ridgway, Assistant Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics | Health Canada (HC)
    • Stephanie Hardy, Manager, Office of Policy and International Collaboration | Health Canada (HC)
    • Kenneth Joly, Policy Analyst, Office of Policy and International Collboration | Health Canada (HC)
    • Jian Wang, Chief, Clinical Evaluation Division, Heamatology & Oncology, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics | Health Canada (HC)
    • Parag Buch, Subject Matter Technical Specialist, Office of Policy and International Collaboration | Health Canada (HC)
    Subject matters:
    • Health

Date Modified: